首页> Clinical epigenetics> Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies.

Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies.

导出 OA

翻译打印收藏纠错

第一作者： Bing,Yang

第一单位： University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA.

作者： Bing,Yang ^[1] ; Tyler,Etheridge ^[1] ; Johnathon,McCormick ^[1] ; Adam,Schultz ^[1] ; Tariq A,Khemees ^[2] ; Nathan,Damaschke ^[1] ; Glen,Leverson ^[1] ; Kaitlin,Woo ^[1] ; Geoffrey A,Sonn ^[3] ; Eric A,Klein ^[4] ; Mike,Fumo ^[5] ; Wei,Huang ^[6] ; David F,Jarrard ^[7]

作者单位： University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA. ^[1] University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA.;Department of Urology, University of Wisconsin, Madison, WI, 53705, USA. ^[2] Stanford University School of Medicine, Stanford, CA, USA. ^[3] Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH, USA. ^[4] Rockford Urologic, Rockford, IL, USA. ^[5] University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA.;Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, 53705, USA. ^[6] University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA. jarrard@urology.wisc.edu.;Department of Urology, University of Wisconsin, Madison, WI, 53705, USA. jarrard@urology.wisc.edu.;Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, 53705, USA. jarrard@urology.wisc.edu.;Molecular and Environmental Toxicology Program, University of Wisconsin, Madison, WI, 53705, USA. jarrard@urology.wisc.edu. ^[7]

关键词 DNA methylation Epigenetics Field defect Prostate cancer